Journal of Pharmaceutical Policy and Practice (Dec 2024)

Frequency, management and impact of adverse events on treatment outcomes in patients with multidrug resistant tuberculosis in Balochistan, Pakistan

  • Sara Rafique,
  • Nafees Ahmad,
  • Shereen Khan,
  • Amjad Khan,
  • Muhammad Atif,
  • Abdul Wahid,
  • Asad Khan,
  • Hira Waheed

DOI
https://doi.org/10.1080/20523211.2024.2332878
Journal volume & issue
Vol. 17, no. 1

Abstract

Read online

ABSTRACTBackground: Early detection, monitoring, and managing adverse events (AEs) are crucial in optimising treatment for multidrug-resistant tuberculosis (MDR-TB) patients.Objectives: To investigate the incidence, factors, management, and impact of AEs on treatment outcomes in MDR-TB patients.Methods: This study reviewed the medical records of 275 MDR-TB patients at Fatimah Jinnah Institute of Chest Diseases in Quetta, Pakistan. Patient information was collected using a designed data collection form. Mann–Whitney U and Kruskal–Wallis tests examined the difference in AEs occurrences based on patients’ characteristics. Multiple binary logistic regression identified factors associated with unsuccessful outcomes, with statistical significance set at a p-value 60 years(OR = 23.481), baseline body weight of 31–60 kg(OR = 0.180), urban residence(OR = 0.296), and experiencing ototoxicity (OR = 0.258) and hypothyroidism (OR = 0.136) were significantly associated with unsuccessful treatment outcomes.Conclusion: AEs were highly prevalent but did not negatively impact treatment outcomes. Patients at higher risk of developing AEs and unsuccessful outcomes should receive special attention for its early management.

Keywords